Inactive Instrument

News GlaxoSmithKline plc London S.E.

Stocks

Pharmaceuticals

End-of-day quote London S.E. Other stock markets
- ^GBX	-

12:33pm	GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment	MT
09:45am	GSK : DZ Bank remains Neutral	ZD

All News

Mentions Relevance

12:33pm	GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment	MT
09:45am	GSK : DZ Bank remains Neutral	ZD
08:51am	GSK : JP Morgan reaffirms its Sell rating	ZD
07:40pm	GSK plc, Q2 2026 Earnings Call, Jul 28, 2026
07-28	GSK plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Gsk plc Declares Second Interim Dividend for the Second Quarter of 2026, Payable on 8 October 2026	CI
07-28	GSK plc: Another beat; we appreciate the new CEO's aggressive intent
07-28	GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint	MT
07-28	GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline -- Update	DJ
07-28	GSK : JP Morgan gives a Sell rating	ZD
07-28	GSK : Bernstein maintains a Buy rating	ZD
07-28	GSK : Jefferies remains its Buy rating	ZD
07-28	GSK to Build New Global Research Center in Cambridge	MT
07-28	GSK Launches Three-year Cost Savings Plan Amid Higher Second-quarter Sales, Lower Profits	MT
07-28	GSK plc Announces Plans to Establish a Major New Global R&D Centre in Cambridge, UK	CI
07-28	GSK unveils its quarterly results, trial data and a new R&D center
07-28	GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline	DJ
07-28	Gsk plc Licensor Hansoh Pharmaceutical Group Announces Positive Results from Second Phase Iii Trial for Ris-Rez in China	CI
07-28	GSK Q2 Core Earnings, Sales Rise; Reaffirms 2026 Guidance	MT
07-28	Earnings Flash (GSK) GSK Posts Q2 Revenue of 8.41B Pounds ($11.17B), vs. FactSet Est of 8.28B Pounds	MT
07-28	GSK to Open New R&D Center in UK	MT
07-28	GSK targets GBP1.9 billion in cost savings as profit beats forecast	AN
07-28	Earnings Flash (GSK) GSK Posts Q2 Core EPS 50.5 Pence, vs. FactSet Est of $46.47 Pence	MT
07-28	GSK Reports Lower H1 Attributable Profit; Turnover Rises	MT
07-28	Glaxo: Q2 Earnings Snapshot	AQ